SARS-CoV-2 Neutralizing Antibody Quantification Assay
Corresponding Organization : University of Veterinary Medicine Hannover, Foundation
Other organizations : Viroclinics Biosciences (Netherlands), VTT Technical Research Centre of Finland, Utrecht University
Variable analysis
- Dilution of sera
- Neutralizing antibody titers (NT50)
- Inactivation of serum samples (56°C for 30 min)
- Initial serum dilution (1:10)
- SARS-CoV-2 Wuhan-Hu-1 virus (200 TCID50)
- Incubation time (1 h at 37°C)
- Vero cell monolayer
- Incubation conditions (37°C, 5% CO2)
- Fixation with 4% Paraformaldehyde (PFA)
- Permeabilization with 80% methanol
- Blocking with 1% BSA in PBS-0.05% Tween 20
- Primary antibody (rabbit polyclonal anti-SARS-CoV-2 nucleocapsid, 1:1,000 dilution)
- Secondary antibody (anti-rabbit-IgG-Alexa Fluor 488, 1:1,000 dilution)
- Washing with PBS-0.05% Tween 20
- Fluorescent cell counting using C.T.L. S6 Ultimate-V Analyzer
- Data analysis using CTL ImmunoSpot® software
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!